Infliximab Extends the Duration until the First Surgery in Patients with Crohn’s Disease

<table>The cumulative nonoperative rate among all 104 patients. The nonoperative rate was inversely proportional to the duration of the disease.</table>

BioMed Research International

fig1

Figure 1

Figure 1: Infliximab Extends the Duration until the First Surgery in Patients with Crohn’s Disease 